SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000878088-10-000056
Filing Date
2010-11-03
Accepted
2010-11-03 16:18:01
Documents
9
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q f3rdqtr1010q11032010final.htm 10-Q 1134524
2 CREDIT AGREEMENT creditagreementworddocumentf.htm EX-10.1 398469
3 EMPLOYMENT AGREEMENT exh102leporeemploymentagreem.htm EX-10.2 143514
4 SEPARATION AGREEMENT exh102kenyonseparationandrel.htm EX-10.3 47578
5 CERTIFICATION exhibit31ceocert.htm EX-31.1 7282
6 CERTIFICATION exhibit31cfocert.htm EX-31.2 7264
7 CERTIFICATION exhibit32ceo.htm EX-32.1 3104
8 CERTIFICATION exhibit32cfo.htm EX-32.2 3413
9 GRAPHIC creditagreementworddocume002.gif GRAPHIC 11036
  Complete submission text file 0000878088-10-000056.txt   1763488
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 101161658
SIC: 2834 Pharmaceutical Preparations